Home / People / Dr. Tilman Weichert
Portrait ofTilman Weichert

Dr. Tilman Weichert

Partner
Rechtsanwalt

CMS Hasche Sigle
Nymphenburger Straße 12
80335 Munich
Germany
Languages German, English, French, Spanish

Stock corporation law, capital markets law, transformation of companies, M&A

more less

Education

Born in 1976 in Würzburg. After A levels in Bavaria commenced studying law in 1997 at the Universities of Augsburg and Lausanne with subject-specific foreign language training in English and French. First state law exam in 2002. 2002-2004 traineeship in the district of the Higher Regional Court in Munich including practice in Pretoria/South Africa. Second state law exam in 2004. 2004-2007 assistant professor at the University of Augsburg, at the chair of Prof. Dr. Thomas M.J. Möllers, doctorate in capital markets law there in 2007. Joined CMS Hasche Sigle in July 2007.

more less

Feed

26/03/2024
CMS advises sellers of Cardior Pharmaceuticals on potential acquisition...
Munich – CMS advises the sellers of Cardior Pharmaceuticals in the potential acquisition of the company by Novo Nordisk. Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart failure. The closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions. It is expected to happen in the second quarter of 2024.A CMS team headed by Lead Partners Stefan-Ulrich Müller, Dr Tilman Weichert and Jörg Schrade advised the sellers of Cardior Pharmaceuticals on all legal aspects of the transaction. Cardior Pharmaceuticals GmbH, based in Hannover, Germany, is a leading clinical-stage bio­phar­ma­ceut­ic­al company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. The company’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. CMS Germany Stefan-Ulrich Müller, Lead Partner Dr Tilman Weichert, Lead Partner Dr Michael Wangemann, Partner Dr Kai Wallisch, Partner Dr Thomas Mühl, Principal Coun­sel Se­basti­an Hummel, Senior As­so­ci­ate Vikt­or­ia Barthel, Senior As­so­ci­ate Mar­i­elouise Emmer, Senior Associate Dr Carl-Friedrich Thoma, Senior Associate Dr Stefan Kühl, Senior Associate Dr Alexander Weinhold, Senior Associate Maria Kucher, Associate Jonas Ohmann, Associate Dr Josephine Doll, Associate Dr Christian Seeburger, Associate Sonja Schanze, Associate, all Corporate/M&A Dr Marie-Luisa Loheide, Associate, Private Clients Jörg Schrade, Lead Partner Eduard Kosavtsev, Senior Associate, both Tax Stefan Lehr, Partner, Antitrust, Competition & Trade Stefan Lüft, Partner, IP Dr Benedikt Forschner, Partner, Labor, Employment & Pensions Dr Markus Kaulartz, Partner Dr Fiona Savary, Counsel Dr Felix Glocker, Senior Associate, all TMC Dr Tilman Niedermaier, Partner Susanne Schwalb, Partner, both Dispute ResolutionPress Con­tact presse@cms-hs. com
17/11/2023
CMS advises Finch Capital on acquisition of the Open Banking FinTechs Qwist...
Munich - The Warsaw-based investment company Crastorehill, which is majority-owned by Finch Capital, has acquired the Berlin-based open banking FinTech Qwist (previously finleap connect) and the open...
11/10/2023
CMS advises IT infrastructure manager Jiliti on acquisition of IT specialist...
Munich – Jiliti, a portfolio company of the French private equity fund Chequers Capital, has acquired StorTrec AG, a major player in IT infrastructures present in ten countries and headquartered in...
06/07/2023
CMS advises fitness technology provider EGYM on €207 million comprehensive...
Munich – German fitness technology and corporate fitness provider EGYM has received €207 million in fresh capital from US investor Affinity Partners and existing investors Mayfair Equity Partners...
11/05/2023
CMS advises Tengelmann Ventures portfolio company Pomélo + Co on the acquisition...
Munich – Pomélo + Co GmbH, which specialises in beauty and personal care, has acquired all the assets of Shyne Labs AG and its range of brands. Through the acquisition, Pomélo + Co is further expanding...
05/04/2023
CMS advises 7-Industries on Series C financing round for space start-up...
Munich – Space start-up Isar Aerospace, developer and manufacturer of launch vehicles for transporting small and medium-sized satellites, has completed a Series C financing round of around EUR 155 million...
28/04/2022
CMS advises sports-tech-com­pany EGYM on acquisition of Gymlib
Munich – The German fitness technology and corporate fitness provider EGYM acquires French competitor Gymlib. With the acquisition, the Munich-based sports-tech-com­pany aims for the market leadership...
16/02/2022
CMS advises digital full-service insurer Coya on merger with insurtech...
Munich – European insurtech company Luko, based in Paris, is acquiring German startup Coya, based in Berlin, in order to grow its European presence and get an insurance license from German regulators...
18/01/2022
Series B financing round: CMS advises US tech company Bruker Corporation...
Frankfurt/Main – PreOmics GmbH, which is headquartered in Martinsried near Munich, has raised EUR 13.5 million in a Series B round of financing from Bruker Corporation, a NASDAQ-listed US tech company...
21/12/2021
CMS advises food start-up infarm on its rise to unicorn status
Berlin - Berlin-based food start-up infarm has raised USD 200 million in a series D funding round. Existing and new investors are involved in the current investment. Among the new investors is the Qatar...
17/12/2021
CMS advises Optimapharm on acquisition of SSS International Clinical Research
Munich – Croatian company Optimapharm d.o.o. has acquired SSS International Clinical Research GmbH. Optimapharm is an international contract research organisation (CRO) which primarily conducts clinical...
20/09/2021
EGYM completes successful USD 41 million round of financing with CMS support
Munich – Munich-based fitness tech start-up EGYM has raised USD 41 million in a Series E round of financing. The round saw Mayfair Equity Partners, a leading growth investor in the technology and consumer...